Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Reader Inquiry: Is Recent Weakness In Sangamo Therapeutics A Buying Opportunity? [Seeking Alpha]

AVEXIS (AVXS) 
Last avexis earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.avexis.com
Company Research Source: Seeking Alpha
Reader Inquiry: Is Recent Weakness In Sangamo Therapeutics A Buying Opportunity?SummaryShares have risen by over 350% in the past year, but they've pulled back by over 25% from their 52-week high.The valuation for the firm appears very reasonable considering the depth of their pipeline and de-risking that´s occurred as a result of progress in the clinic and partnering.While the company is definitely an M&A candidate, prospects are excellent (and upside much greater) if they continue along as an independent enterprise.Recent events including the acquisition of AveXis, partnership with Kite/Gilead and January´s gene therapy team-up with Pfizer strengthen the bullish thesis.The main catalyst in the next few quarters will be preliminary data across their lead programs. Show less Read more
Impact Snapshot
Event Time:
AVXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AVXS alerts
Opt-in for
AVXS alerts

from News Quantified
Opt-in for
AVXS alerts

from News Quantified